LobbyingData.com Logo

Qorvo (QRVO) all U.S. Lobbying: all historical lobbying contracts, government bills & agencies, and critical issues lobbied on.


Discover Qorvo’s lobbying activities with our comprehensive dataset, offering insights on spending, bills, and issues from 1999-present. Analyze data by company, lobbyist, issue, and more through our intelligently crafted data design. Dataset updated weekly.


Using our intelligently designed and intuitive dataset, you can quickly understand how Qorvo (QRVO) is lobbying the U.S. government, how much they’re spending on it, and most importantly – the bills and specific issues on which they lobby.

Gain an informational edge with our Lobbying Data Intelligence. Perform analysis by company, lobbyist, lobbying firm, government agency, or issue.

For lobbying firms: understand your competitors. Understand who is registering with who. Gain insight on quarterly reports and specific issues other firms are lobbying on.

Our lobbying data is collected and aggregated from the U.S. Senate Office of Public Records from 1999-present and is updated on a regular basis. We utilize advanced data science techniques to ensure accurate data points are collected and ingested, match similar entities across time, and tickerize publicly traded companies that lobby.

Our comprehensive and advanced lobbying database is completed with all the information you need, with more than 1.6 million lobbying contracts ready-for-analysis. We include detailed information on all aspects of federal lobbying, including the following fascinating attributes, among much more:

1. Clients: The publicly traded company, privately owned company, interest group, NGO, or state or local government that employs or retains a lobbyist or lobbying firm.

2. Registrants (Lobbying Firms): Either the name of the lobbying firm hired by the client, or the name of the client if the client employs in-house lobbyists.

3. Lobbyists: The names and past government work experience of the individual lobbyists working on a lobbying contract. 3. General Issues: The general issues for which clients lobby on (ex: ENV – Environment, TOB – Tobacco, FAM – Family Issues/Abortion).

4. Specific Issues: A long text description of the exact bills and specific issues for which clients lobby on.

5. Bills Lobbied On: The exact congressional bills and public/private laws lobbied on, parsed from lobbying report specific issues (ex: H.R. 2347, S. 1117, Tax Cuts and Jobs Act).

6. Agencies Lobbied: The names of one or more of 250+ government agencies lobbied on in the contract (ex: White House, FDA, DOD).

7. Foreign Entities: The names and origin countries of entities affiliated with the client (ex: BNP Paribas: France).

Gain access to our highly unique and actionable U.S. lobbying database. Further information on LobbyingData.com and our alternative datasets and database can be found on our website, or by contacting [email protected].

Frequently Asked Questions

What is Qorvo (QRVO) lobbying for?


Qorvo, a company in the U.S., has submitted ten recent lobbying contracts. They have hired four lobbying firms, namely Mchugh Lemay Assoc., Hawley Llc, Llc, Crossroads Strategies, and Clark Street Associates. The general issues they lobbied on include Medical/Disease Research/Clinical Labs, Defense, Health Issues, Science/Technology, and Budget/Appropriations. The specific issues they lobbied on include the National Defense Authorization Act for FY2023, issues related to pathogen testing for COVID and other diseases, implementation of the Chips and Science Act of 2022 (P.L. 117-167), among others. The government agencies they lobbied include the Office of Science & Technology Policy (OSTP), Centers for Disease Control & Prevention (CDC), House of Representatives, Department of Health & Human Services (HHS), Senate, and Department of Defense (DOD).


One could infer that Qorvo is lobbying on these issues to gain support from the U.S. government for their research and development efforts in the fields of defense, medical, and technology. They are focusing on the National Defense Authorization Acts and Defense Appropriations Acts, as well as CDC and HHS, to advance their defense technology research and secure contracts. Similarly, their lobbying efforts towards the Chips and Science Act of 2022 and funding for pathogen testing reveal their interests in advancing technology and healthcare research.

Subscribe To Our Newsletter

gain actionable insights from our alternative data

More to explore